-
ICD-10-CM Codes
›
-
Z00-Z99
›
-
Z77-Z99
›
-
Z79-
›
-
2023 ICD-10-CM Diagnosis Code Z79.83
2023 ICD-10-CM Diagnosis Code Z79.83
Long term (current) use of bisphosphonates
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
- Z79.83 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2023 edition of ICD-10-CM Z79.83 became effective on October 1, 2022.
- This is the American ICD-10-CM version of Z79.83 - other international versions of ICD-10 Z79.83 may differ.
The following code(s) above
Z79.83 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
- Applicable To annotations, or
- Code Also annotations, or
- Code First annotations, or
- Excludes1 annotations, or
- Excludes2 annotations, or
- Includes annotations, or
- Note annotations, or
- Use Additional annotations
that may be applicable to
Z79.83:
- Z00-Z99
2023 ICD-10-CM Range Z00-Z99
Factors influencing health status and contact with health servicesNote- Z codes represent reasons for encounters. A corresponding procedure code must accompany a Z code if a procedure is performed. Categories Z00-Z99 are provided for occasions when circumstances other than a disease, injury or external cause classifiable to categories A00-Y89 are recorded as 'diagnoses' or 'problems'. This can arise in two main ways:
- (a) When a person who may or may not be sick encounters the health services for some specific purpose, such as to receive limited care or service for a current condition, to donate an organ or tissue, to receive prophylactic vaccination (immunization), or to discuss a problem which is in itself not a disease or injury.
- (b) When some circumstance or problem is present which influences the person's health status but is not in itself a current illness or injury.
Factors influencing health status and contact with health services - Z77-Z99
2023 ICD-10-CM Range Z77-Z99
Persons with potential health hazards related to family and personal history and certain conditions influencing health statusCode Also- any follow-up examination (Z08-Z09)
Persons with potential health hazards related to family and personal history and certain conditions influencing health status - Z79
ICD-10-CM Diagnosis Code Z79
Long term (current) drug therapy
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Code Also- any therapeutic drug level monitoring (Z51.81)
Includes- long term (current) drug use for prophylactic purposes
Type 2 Excludes- drug abuse and dependence (F11-F19)
- drug use complicating pregnancy, childbirth, and the puerperium (O99.32-)
Long term (current) drug therapy
Approximate Synonyms
- Long term current use of bisphosphonate
- Long term current use of bisphosphonates
Present On AdmissionPOA Help
"Present On Admission" is defined as present at the time the order for inpatient admission occurs — conditions that develop during an outpatient encounter, including emergency department, observation, or outpatient surgery, are considered POA.
- Z79.83 is considered exempt from POA reporting.
ICD-10-CM Z79.83 is grouped within Diagnostic Related Group(s) (MS-DRG v40.0):
- 949 Aftercare with cc/mcc
- 950 Aftercare without cc/mcc
Convert Z79.83 to ICD-9-CM
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
ICD-10-CM Codes Adjacent To Z79.83
Z79.633 Long term (current) use of mitotic inhibitor
Z79.634 Long term (current) use of topoisomerase inhibitor
Z79.64 Long term (current) use of myelosuppressive agent
Z79.69 Long term (current) use of other immunomodulators and immunosuppressants
Z79.8 Other long term (current) drug therapy
Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels
Z79.810 Long term (current) use of selective estrogen receptor modulators (SERMs)
Z79.811 Long term (current) use of aromatase inhibitors
Z79.818 Long term (current) use of other agents affecting estrogen receptors and estrogen levels
Z79.82 Long term (current) use of aspirin
Z79.83
Long term (current) use of bisphosphonates
Z79.84 Long term (current) use of oral hypoglycemic drugs
Z79.85 Long-term (current) use of injectable non-insulin antidiabetic drugs
Z79.89 Other long term (current) drug therapy
Z79.890 Hormone replacement therapy
Z79.891 Long term (current) use of opiate analgesic
Z79.899 Other long term (current) drug therapy
Z80 Family history of primary malignant neoplasm
Z80.0 Family history of malignant neoplasm of digestive organs
Z80.1 Family history of malignant neoplasm of trachea, bronchus and lung
Z80.2 Family history of malignant neoplasm of other respiratory and intrathoracic organs
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.